Immune-mediated skin inflammation is similar in severe atopic dermatitis patients with or without filaggrin mutation

Acta Dermato-Venereologica

Volumn 96, Issue 5, 2016, Pages 645-650

  Dajnoki, Zsolt ^a   Béke, Gabriella ^a   Mócsai, Gábor ^a   Kapitány, Anikó ^a   Gáspár, Krisztián ^a   Hajdu, Krisztina ^a   Emri, Gabriella ^a   Nagy, Bence ^b   Kovács, Ilona ^b   Beke, Lívia ^b   Dezső, Balázs ^b   Szegedi, Andrea ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Atopic dermatitis; Filaggrin; Immunohistochemistry; Innate immunity; Thymic stromal lymphopoietin

Indexed keywords

CD3 ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; FILAGGRIN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN E; INTERLEUKIN 33; KI 67 ANTIGEN; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE; INTERMEDIATE FILAMENT PROTEIN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; EOSINOPHIL COUNT; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LYMPHOCYTE COUNT; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN BIOPSY; T LYMPHOCYTE; TH2 CELL; WILD TYPE; ADOLESCENT; BIOPSY; CHILD; GENETICS; GENOTYPE; IMMUNOLOGY; INFLAMMATION; KERATINOCYTE; MUTATION; YOUNG ADULT;

ADOLESCENT; BIOPSY; CHEMOKINE CCL27; CHILD; CYTOKINES; DERMATITIS, ATOPIC; GENOTYPE; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-33; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; LYMPHOCYTE COUNT; MUTATION; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84973635852     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2272     Document Type: Article

References (40)

1. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145–151.
2. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 2011; 242: 10–30.
3. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112: S118–127.
4. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009; 124: R7–R12.
5. Chen YC, Wu CS, Lu YW, Li WC, Ko YC, Yu HS et al. Atopic dermatitis and non-atopic hand eczema have similar negative impacts on quality of life: implications for clinical significance. Acta Derm Venereol 2013; 93: 749–750.
6. Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009; 129: 1878–1891.
7. McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006; 118: 202–208.
8. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129: 14–30.
9. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–246.
10. Wittmann M, Werfel T. Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases. Curr Opin Allergy Clin Immunol 2006; 6: 329–334.
11. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007; 28: 248–251.
12. Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012; 30: 329–334.
13. Elias PM, Schmuth M. Abnormal skin barrier in the etio-pathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009; 9: 437–446.
14. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315–1327.
15. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–446.
16. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337–342.
17. O’Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122: 689–693.
18. Mocsai G, Gaspar K, Nagy G, Irinyi B, Kapitany A, Biro T, et al. Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis. Br J Dermatol 2014; 170: 617–624.
19. Winge MC. Atopic dermatitis severity and skin barrier impairment. Br J Dermatol 2014; 170: 490–491.
20. Akdis CA, Akdis M. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clinical and experimental allergy. J Br Soc Allergy Clin Immunol 2003; 33: 1618–1621.
21. O’Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009; 124: R2–6.
22. Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285–1294.
23. Bussmann C, Weidinger S, Novak N. Genetics of atopic dermatitis. J Dtsch Dermatol Ges 2011; 9: 670–676.
24. Bieber T. Atopic dermatitis. Ann Dermatol 2010; 22: 125–137.
25. Son ED, Kim HJ, Park T, Shin K, Bae IH, Lim KM et al. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion. J Dermatol Sci 2014; 74: 64–71.
26. Al-Jaberi H, Marks R. Studies of the clinically uninvolved skin in patients with dermatitis. Br J Dermatol 1984; 111: 437–443.
27. Jensen JM, Folster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423–1431.
28. Zhou J, Chen Y, Huang Y, Long J, Wan F, Zhang S. Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer. Oncol Lett 2013; 6: 1128–1132.
29. Kawahira K. Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in malignant and nonmalignant skin diseases. Arch Dermatol Res 1999; 291: 413–418.
30. Lee EB, Kim KW, Hong JY, Jee HM, Sohn MH, Kim KE. Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr Allergy Immunol 2010; 21: e457–460.
31. Alysandratos KD, Angelidou Aea. Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Ann Allergy Asthma Immunol 2010; 105: 403–404.
32. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673–680.
33. He R, Geha RS. Thymic stromal lymphopoietin. Ann N Y Acad Sci 2010; 1183: 13–24.
34. Sano Y, Masuda K, Tamagawa-Mineoka R, Matsunaka H, Murakami Y, Yamashita R, et al. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clin Exp Immunol 2013; 171: 330–337.
35. Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimaki S, et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132: 1392–1400.
36. Tamagawa-Mineoka R, Okuzawa Y, Masuda K, Katoh N. Increased serum levels of interleukin 33 in patients with atopic dermatitis. J Am Acad Dermatol 2014; 70: 882–888.
37. Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ ALP/ILC). J Immunol 2000; 164: 3465–3470.
38. Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003; 111: 592–597.
39. Cole C, Kroboth K, Schurch NJ, Sandilands A, Sherstnev A, O’Regan GM, et al. Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 134: 82–91.
40. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Why-not J, Novitskaya I, Cardinale I, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 2007; 119: 1210–1217.